Clinical Trial

Gastroparesis Registry 4

Study acronym: GpR4
Recruiting
View on ClinicalTrials.gov →
Summary
The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2023-05-04; most recent amendment 2026-03-30.
Status change: Not Yet Recruiting → Recruiting 2024-09-20
Trial Details
NCT Number NCT05846802
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: Texas Tech University Health Sciences Center, El Paso, Temple University, University of Louisville, Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Massachusetts General Hospital, Wake Forest University
Conditions Gastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus Type I, Gastroparesis Due to Diabetes Mellitus Type II, Functional Disorder of Gastrointestinal Tract, Gastro-Intestinal Disorder
Enrollment 250 participants
Start Date 2024-09-20
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-03